Stryker Other Non-Current Liabilities 2010-2024 | SYK

Stryker other non-current liabilities from 2010 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Stryker other non-current liabilities for the quarter ending September 30, 2024 were $2.322B, a 26.75% increase year-over-year.
  • Stryker other non-current liabilities for 2023 were $1.93B, a 31.56% increase from 2022.
  • Stryker other non-current liabilities for 2022 were $1.467B, a 19.4% decline from 2021.
  • Stryker other non-current liabilities for 2021 were $1.82B, a 8.31% decline from 2020.
Stryker Annual Other Non-Current Liabilities
(Millions of US $)
2023 $1,930
2022 $1,467
2021 $1,820
2020 $1,985
2019 $1,661
2018 $978
2017 $881
2016 $764
2015 $980
2014 $977
2013 $1,300
2012 $987
2011 $872
2010 $1,120
2009 $1,035
Stryker Quarterly Other Non-Current Liabilities
(Millions of US $)
2024-09-30 $2,322
2024-06-30 $1,965
2024-03-31 $1,903
2023-12-31 $1,930
2023-09-30 $1,832
2023-06-30 $1,846
2023-03-31 $1,587
2022-12-31 $1,467
2022-09-30 $1,577
2022-06-30 $1,793
2022-03-31 $1,881
2021-12-31 $1,820
2021-09-30 $1,960
2021-06-30 $1,965
2021-03-31 $1,955
2020-12-31 $1,985
2020-09-30 $1,604
2020-06-30 $1,523
2020-03-31 $1,733
2019-12-31 $1,661
2019-09-30 $1,439
2019-06-30 $1,385
2019-03-31 $1,363
2018-12-31 $978
2018-09-30 $892
2018-06-30 $877
2018-03-31 $912
2017-12-31 $881
2017-09-30 $1,209
2017-06-30 $1,113
2017-03-31 $1,075
2016-12-31 $764
2016-09-30 $1,116
2016-06-30 $1,100
2016-03-31 $968
2015-12-31 $980
2015-09-30 $1,369
2015-06-30 $1,349
2015-03-31 $1,307
2014-12-31 $977
2014-09-30 $1,449
2014-06-30 $1,277
2014-03-31 $1,294
2013-12-31 $1,300
2013-09-30 $1,079
2013-06-30 $1,066
2013-03-31 $1,087
2012-12-31 $987
2012-09-30 $1,089
2012-06-30 $1,071
2012-03-31 $1,137
2011-12-31 $872
2011-09-30 $1,209
2011-06-30 $1,218
2011-03-31 $1,195
2010-12-31 $1,120
2010-09-30 $1,064
2010-06-30 $1,023
2010-03-31 $1,027
2009-12-31 $1,035
2009-09-30 $820
2009-06-30 $791
2009-03-31 $778
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $138.991B $20.498B
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $198.127B 25.27
Boston Scientific (BSX) United States $131.097B 37.69
EssilorLuxottica (ESLOY) France $109.895B 0.00
Medtronic (MDT) Ireland $103.904B 15.43
Haleon (HLN) United Kingdom $43.864B 28.50
Lonza Group Ag (LZAGY) Switzerland $42.859B 0.00
GE HealthCare Technologies (GEHC) United States $36.052B 18.70
ResMed (RMD) United States $34.830B 28.62
Terumo (TRUMY) Japan $28.875B 0.00
Koninklijke Philips (PHG) Netherlands $23.602B 18.07
Zimmer Biomet Holdings (ZBH) United States $21.325B 13.58
Insulet (PODD) United States $18.698B 74.46
Baxter (BAX) United States $15.062B 9.80
Smith & Nephew SNATS (SNN) United Kingdom $10.781B 0.00
BellRing Brands (BRBR) United States $9.800B 39.43
Bio-Rad Laboratories (BIO) United States $9.168B 31.16
Demant (WILYY) Denmark $7.926B 0.00
Lantheus Holdings (LNTH) United States $6.208B 14.42
Prestige Consumer Healthcare (PBH) United States $3.889B 19.34
ICU Medical (ICUI) United States $3.840B 36.56
Haemonetics (HAE) United States $3.789B 18.49
Perrigo (PRGO) Ireland $3.513B 10.34
Envista Holdings (NVST) United States $3.218B 23.97
QuidelOrtho (QDEL) United States $3.016B 19.41
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.864B 18.36
Neogen (NEOG) United States $2.609B 30.10
LeMaitre Vascular (LMAT) United States $2.071B 50.34
Green Thumb Industries (GTBIF) United States $1.678B 29.37
AtriCure (ATRC) United States $1.498B 0.00
InMode (INMD) Israel $1.434B 8.63
AdaptHealth (AHCO) United States $1.383B 9.88
Maravai LifeSciences Holdings (MRVI) United States $1.356B 0.00
BioLife Solutions (BLFS) United States $1.271B 0.00
Curaleaf Holdings (CURLF) Canada $0.968B 0.00
Owens & Minor (OMI) United States $0.965B 7.54
CeriBell (CBLL) United States $0.964B 0.00
Phibro Animal Health (PAHC) United States $0.879B 15.49
Evolus (EOLS) United States $0.690B 0.00
Omeros (OMER) United States $0.597B 0.00
Capricor Therapeutics (CAPR) United States $0.594B 0.00
VAREX IMAGING (VREX) United States $0.584B 25.75
Surmodics (SRDX) United States $0.568B 0.00
Verano Holdings (VRNOF) United States $0.452B 0.00
Cresco Labs (CRLBF) United States $0.439B 0.00
Quanterix (QTRX) United States $0.403B 0.00
ZimVie (ZIMV) United States $0.375B 31.63
Biote (BTMD) United States $0.331B 7.26
Valneva SE (VALN) France $0.324B 0.00
Viemed Healthcare (VMD) United States $0.311B 29.56
Canopy Growth (CGC) Canada $0.308B 0.00
Sanara MedTech (SMTI) United States $0.294B 0.00
Cerus (CERS) United States $0.293B 0.00
OraSure Technologies (OSUR) United States $0.272B 18.20
Zynex (ZYXI) United States $0.263B 55.00
High Tide (HITI) Canada $0.242B 100.33
Aurora Cannabis (ACB) Canada $0.234B 0.00
Utah Medical Products (UTMD) United States $0.207B 14.29
Sanuwave Health (SNWV) United States $0.201B 2.82
MacroGenics (MGNX) United States $0.200B 0.00
Organigram Holdings (OGI) Canada $0.197B 0.00
TerrAscend (TSNDF) Canada $0.190B 0.00
Brainsway (BWAY) Israel $0.174B 92.40
FitLife Brands (FTLF) United States $0.145B 18.17
Jin Medical (ZJYL) China $0.133B 0.00
TriSalus Life Sciences (TLSI) United States $0.124B 0.00
Quipt Home Medical (QIPT) United States $0.107B 0.00
Fonar (FONR) United States $0.096B 10.81
Oramed Pharmaceuticals (ORMP) United States $0.096B 0.00
Veru (VERU) United States $0.095B 0.00
Exagen (XGN) United States $0.091B 0.00
InterCure (INCR) Israel $0.068B 0.00
Rockwell Medical (RMTI) United States $0.067B 34.67
Apyx Medical (APYX) United States $0.059B 0.00
Jushi Holdings (JUSHF) United States $0.056B 0.00
Ayr Wellness (AYRWF) United States $0.051B 0.00
Cytosorbents (CTSO) United States $0.050B 0.00
Modular Medical (MODD) United States $0.048B 0.00
Safety Shot (SHOT) United States $0.044B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Allurion Technologies (ALUR) United States $0.023B 0.00
Nephros (NEPH) United States $0.016B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Innovative Eyewear (LUCY) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Trinity Biotech (TRIB) Ireland $0.006B 0.00
Agape ATP (ATPC) $0.006B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Sharps Technology (STSS) United States $0.003B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 12.74
SNDL (SNDL) Canada $0.000B 0.00